Relapse and non-relapse prediction using a sensitive circulating tumor DNA assay during colorectal cancer postoperative surveillance

Tomoko Sasaki, Takeshi Iwaya, Mizunori Yaegashi, Masashi Idogawa, Hayato Hiraki, Masakazu Abe, Yuka Koizumi, Noriyuki Sasaki, Akiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, Shoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, Mari Masuda, Masashi Fujita, Hidewaki Nakagawa, Fumiaki Takahashi, Yasushi Sasaki, Takashi Tokino, Satoshi S. Nishizuka
doi: https://doi.org/10.1101/2022.09.03.22279571

Article Information

doi 
https://doi.org/10.1101/2022.09.03.22279571
History 
  • September 6, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Tomoko Sasaki1,
  2. Takeshi Iwaya2,*,
  3. Mizunori Yaegashi1,
  4. Masashi Idogawa3,
  5. Hayato Hiraki4,
  6. Masakazu Abe4,5,
  7. Yuka Koizumi1,4,
  8. Noriyuki Sasaki1,4,
  9. Akiko Yashima-Abo4,
  10. Ryosuke Fujisawa1,
  11. Fumitaka Endo2,
  12. Shoichiro Tange3,
  13. Tomomi Hirano3,
  14. Koki Otsuka6,
  15. Akira Sasaki1,
  16. Mari Masuda7,
  17. Masashi Fujita8,
  18. Hidewaki Nakagawa8,
  19. Fumiaki Takahashi9,
  20. Yasushi Sasaki3,10,
  21. Takashi Tokino3 and
  22. Satoshi S. Nishizuka4
  1. 1Department of Surgery, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
  2. 2Department of Clinical Oncology, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
  3. 3Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo, Japan
  4. 4Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences, Yahaba, Iwate, Japan
  5. 5Department of Urology, Iwate Medical University School of Medicine, Yahaba, Iwate, Japan
  6. 6Department of Surgery, Fujita health University School of Medicine, Toyoake, Aichi, Japan
  7. 7Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan
  8. 8Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
  9. 9Division of Medical Engineering, Department of Information Science, Iwate Medical University, Yahaba, Iwate, Japan
  10. 10Biology Division, Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo, Japan
  1. ↵*Corresponding
    Address corresponding to: Takeshi Iwaya, MD, PhD, Department of Clinical Oncology, Iwate Medical University School of Medicine, 2-1-1 Idai-dori, Yahaba, Iwate, 028-3695, Japan. Tel: +81-196-51-5111; Fax: +81-199-07-8471; E-mail: tiwaya{at}iwate-med.ac.jp.
Back to top
Posted September 06, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Relapse and non-relapse prediction using a sensitive circulating tumor DNA assay during colorectal cancer postoperative surveillance
Tomoko Sasaki, Takeshi Iwaya, Mizunori Yaegashi, Masashi Idogawa, Hayato Hiraki, Masakazu Abe, Yuka Koizumi, Noriyuki Sasaki, Akiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, Shoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, Mari Masuda, Masashi Fujita, Hidewaki Nakagawa, Fumiaki Takahashi, Yasushi Sasaki, Takashi Tokino, Satoshi S. Nishizuka
medRxiv 2022.09.03.22279571; doi: https://doi.org/10.1101/2022.09.03.22279571
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area